TIMH
VRTX icon

Tilt Investment Management Holdings’s Vertex Pharmaceuticals VRTX Stock Holding History

Tilt Investment Management Holdings’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$428K Sell
1,052
-325
-24% -$120K 0.46% 54
2023
Q3 		$479K Hold
1,377
– – 0.34% 88
2023
Q2 		$485K Buy
+1,377
New +$464K 0.32% 91

Other funds holding VRTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Tilt Investment Management Holdings's VRTX Position: Q4 2023 in Review

Tilt Investment Management Holdings reduced its Vertex Pharmaceuticals (VRTX) stake by 24% in Q4 2023, selling an estimated $120K and leaving 1,052 shares worth $428K. The position accounts for 0.46% of the portfolio, ranked #54.

Tilt Investment Management Holdings first reported a position in VRTX in Q2 2023 and has held it in 3 quarters since. The position peaked at $485K in Q2 2023. 1,440 funds tracked by Wall St. Rank hold VRTX as of Q4 2023.

  • Tilt Investment Management Holdings held 1,052 shares of Vertex Pharmaceuticals worth $428K as of Q4 2023.
  • Tilt Investment Management Holdings sold 325 Vertex Pharmaceuticals shares in Q4 2023, an estimated $120K.
  • Vertex Pharmaceuticals made up 0.46% of Tilt Investment Management Holdings's portfolio in Q4 2023, its #54 holding.
  • Tilt Investment Management Holdings first reported a position in Vertex Pharmaceuticals in Q2 2023 and has held it in 3 quarters since.
  • Tilt Investment Management Holdings's Vertex Pharmaceuticals position peaked at $485K in Q2 2023.
  • 1,440 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2023.

Based on Tilt Investment Management Holdings's 13F filing for Q4 2023, filed 31 Jan 2024.